Xiaolan Feng
South China Agricultural University(CN)Island Health(CA)BC Cancer Agency(CA)Guangxi Medical University(CN)University of Calgary(CA)South China Normal University(CN)Ningxia University(CN)Shaoguan University(CN)Northwest University(US)North West Agriculture and Forestry University(CN)First Affiliated Hospital of GuangXi Medical University(CN)Ningxia Medical University(CN)Environmental Research Institute(GB)Ningxia Medical University General Hospital(CN)Institute of Medicinal Plant Development(CN)Ningxia Center for Diseases Prevention and Control(CN)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Gastrointestinal Tumor Research and Treatment, Soft tissue tumor case studies
Most-Cited Works
- → Different HATS of the ING1 gene family(2002)154 cited
- ING1 represses transcription by direct DNA binding and through effects on p53.(2003)
- → Whole-genome and transcriptome analysis enhances precision cancer treatment options(2022)112 cited
- → REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors(2012)108 cited
- → Tethering by lamin A stabilizes and targets the ING1 tumour suppressor(2008)90 cited
- → HSP70 Induction by ING Proteins Sensitizes Cells to Tumor Necrosis Factor Alpha Receptor-Mediated Apoptosis(2006)62 cited
- → ING1a expression increases during replicative senescence and induces a senescent phenotype